Skip to main content

Together we are beating cancer

Donate now

Science & Technology

Read the latest in pre-clinical research, drug discovery and new technologies in cancer
Showing 12 out of 1578 results
Animated depiction of COVID-19 virus

We spoke with Professor Kev Dhaliwal, chief investigator of the SPIKE-1 trial, about how repurposing a drug in a COVID-19 trial could benefit people with cancer. We spoke with Professor Kev Dhaliwal, chief investigator of the SPIKE-1 trial, about how repurposing a drug in a COVID-19 trial could benefit people with cancer.

by Catherine Pickworth | Analysis | 2 March 2021

2 March 2021

A photo of some blue and white pills

New research shows a type of aggressive blood cancer could be made more sensitive to chemotherapy using an antibiotic currently available to treat diarrhoea. New research shows a type of aggressive blood cancer could be made more sensitive to chemotherapy using an antibiotic currently available to treat diarrhoea.

by Cancer Research UK | News | 24 February 2021

24 February 2021

A team of Cancer Research UK-funded scientists have been investigating the role of exercise in reducing the risk of liver cancer in mice A team of Cancer Research UK-funded scientists have been investigating the role of exercise in reducing the risk of liver cancer in mice

by Alex Lathbridge | Analysis | 15 February 2021

15 February 2021

  • Science & Technology
  • Health & Medicine

Discovering the BRCA2 gene – 25 years on

25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off. 25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off.

by Katie Roberts | Analysis | 14 January 2021

14 January 2021

We asked two of our protein specialists, who are trying to understand how the way proteins fold affect cancer outcomes, to give their verdict on the news. We asked two of our protein specialists, who are trying to understand how the way proteins fold affect cancer outcomes, to give their verdict on the news.

by Joanna Lewin | Analysis | 23 December 2020

23 December 2020